Iopamidol Injectable Solution 37%, 61%, 76%, and 78% Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 37%, 61%, 76%, and 78%
Reference Brands: Isovue(US), Iopamiro(EU)
Category: Contrast Agent
Iopamidol is a contrast agent that enhances X-ray and CT images by increasing tissue radiopacity. It provides clear visualization of blood vessels, organs, and tissues, aiding accurate diagnosis. Benefits include high-quality imaging, rapid excretion, safety, and improved diagnostic accuracy in cardiovascular and neurovascular assessments worldwide.
Product Description:
Iopamidol injectable solution, marketed as Isovue in the US and Iopamiro in the EU, is approved for use as a contrast agent in X-ray and CT imaging. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability, facilitating high-quality diagnostic imaging in healthcare systems globally.
Iopamidol Injectable Solution — third party manufacturing & bulk supply
Iopamidol Injectable Solution 37%, 61%, 76%, and 78% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Iopamidol Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Iopamidol Injectable Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Iopamidol is used as a contrast agent in X-ray and CT imaging to enhance the visibility of blood vessels, organs, and tissues, helping in the diagnosis of abnormalities in the body.
Iopamidol is made from a non-ionic, iodinated compound that allows X-rays to be absorbed, providing clearer imaging during diagnostic procedures.
Iopamidol is marketed under trade names such as Isovue‑200, Isovue‑250, Isovue‑300, Isovue‑370, Isovue‑M‑200, and Isovue‑M‑300.
The original brand Isovue is manufactured by Bracco Diagnostics, Inc., and generic or licensed versions are produced by multiple pharmaceutical companies worldwide.
The generic name is Iopamidol.
The primary brand name is Isovue, with regional variants like Isovue‑200, Isovue‑250, Isovue‑300, Isovue‑370, Isovue‑M‑200, and Isovue‑M‑300.
Iopamidol is manufactured in various regions, including the United States, Europe, and Asia, depending on the company and regional regulatory approvals.
Related Products
Gadobenate Dimeglumine
Strength:
529 mg/mL
Form: Injection
Reference Brands: MultiHance (USA)
View DetailsGadopiclenol
Strength:
0.25 mmol/mL
Form: Injection
Reference Brands: Elucirem (USA), Vueway(EU)
View DetailsPerflutren
Strength:
0.19 mg/ ml
Form: Injection
Reference Brands: Definity (USA), Optison (USA), Luminity (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers